All posts by : Felistas

Ovarian cancer has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting following first-line chemotherapy.

In 1991, U.S. sociologist Scott Feld wrote, “Your friends have more friends than you do.” Feld’s so-called friendship paradox states that the friends of any given person have more friends on average than the person themselves. This is based on a simple probability calculation: Well-connected people are more likely to appear in other people’s social circles.

Rakesh Jain Ph.D., Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk Cook Professor of Radiation Oncology at Harvard Medical School, is senior author of a new study in PNAS, titled “Targeting EPHB2/ABL1 Restores Anti-Tumor Immunity in Preclinical Models of Ependymoma.”

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal. But weight loss doesn’t discriminate between fat and muscle. Patients using GLP-1 drugs can experience rapid and substantial muscle loss, accounting for as much as 40% of their total weight loss. So how can we lose weight without also losing critical muscle?

Whenever 27-year-old Nathan Kerr stops by the office of his 81-year-old mentor Frank Booth, Kerr often finds Booth running on a treadmill.

Just over one in 20 adults in England both smoke and vape, according to a new study by UCL researchers.

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for neurological diseases by overcoming one of medicine’s most difficult challenges: the blood–brain barrier. Led by Dr. David Dickens, their findings offer new hope for patients with conditions including Alzheimer’s, and Parkinson’s disease, brain tumors, and epilepsy.

Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.

Step into any supermarket or pharmacy, and you’ll find aisles brimming with products designed to make you smell “fresh,” feel “clean,” or somehow achieve a level of “purity” that no human body naturally possesses.